Objective: To study the role of the prenatal environment in regulating reproductive development by measuring the prospective association between umbilical cord concentrations of sex hormone binding globulin (SHBG; principal regulator of sex steroid activity), bioavailable sex steroids, and age at menarche. Design: Prospective population-based cohort. Setting: Not applicable. Patient(s): In 286 female members of the Western Australian Pregnancy (Raine) cohort, concentrations of SHBG and steroids (estrogens: estrone, estradiol, estriol and estetrol [E4]; androgens: total testosterone, D4-androstenedione, androstenedione and dehydroepiandrosterone) were measured by liquid chromatography-tandem mass spectrometry from archived umbilical cord blood samples collected at birth. Bioavailable concentrations of testosterone and estradiol were calculated along with total composite measures of androgen and estrogen bioactivity. SHBG was measured by ELISA. Intervention(s): None. Main Outcome Measure(s): Age of menarche was calculated from date of menarche, collected prospectively by questionnaire sent home with participants at the year 10 follow-up. Result(s): Higher maternal education, higher body mass index, and the presence of antepartum hemorrhage were all significantly associated with earlier age at menarche. The bioavailable sex steroid measures accounted for 8.3% of the variance in age at menarche. Further, both SHBG and E4 concentrations accounted for a significant proportion of unique variance in age at menarche. Conclusion(s): Lower SHBG and higher E4 concentrations in umbilical cord blood were associated with earlier age at menarche. These results suggest that the prenatal sex steroid environment contributes toward pubertal development and age at menarche. (Fertil Steril Ò 2018;110:965-73. Ó2018 by American Society for Reproductive Medicine.) El resumen está disponible en Español al final del artículo.
M enarche is a relatively late event in pubertal development, and complex genetic, environmental and endocrine factors regulate the onset and tempo of puberty in girls (1) . Understanding environmental factors influencing age at menarche is of broad clinical interest as extremes of menarchal age (early and late) are associated with later life health risks, including metabolic and cardiovascular disease (2) . Early menarche is a risk factor for diabetes, cardiovascular disease, and obesity in later life (3, 4) . In overweight girls, earlier age at menarche may be a marker for polycystic ovary syndrome (5) , which carries significant adverse long-term health consequences (6) . Multiple studies confirm that earlier age at menarche is also a risk marker for breast cancer (7) .
There is growing evidence that the prenatal environment may modify subsequent reproductive development (8, 9) , which is a form of developmental plasticity and if leading to epigenetic modifications may have a heritable component (10) . The human fetus is exposed to sex steroids from placental, gonadal, and adrenal sources. The placenta produces large amounts of free and conjugated androgens and estrogens from fetal adrenal precursors (11) . During pregnancy, the placenta makes considerable amounts of estrone (E1) and estriol (E3) and expresses the aromatase enzyme (CYP19) which metabolises testosterone (T) to estradiol (E2), and D4-androstenedione (A4) to E1. A fourth estrogen, estetrol (E4, also known as 15a-hydroxyestriol), is synthesised exclusively by the fetal liver, primarily from E2 and E3 precursors (12) . The fetal adrenals also synthesise large amounts of the sulphated dehydroepiandrosterone (DHEA), a weak androgen. DHEA is de-sulphated in the placenta and further metabolised to A4. Sex hormone binding globulin (SHBG) is a glycoprotein produced mainly by the liver, which binds the sex hormones, androgens and estrogens and its secretion is modulated by systemic insulin (13) and is reported to be an independent predictor of the metabolic syndrome and Type II diabetes (14, 15) . Current evidence suggests that SHBG plays a role in the subsequent development of Type II diabetes (16, 17) , and in adults, circulating SHBG is predictive of the degree of insulin resistance and glycaemia at 6-year followup, irrespective of adjustment for baseline insulin and T levels (17) . As only the free (unbound) fraction of sex steroids is biologically active, circulating concentrations of SHBG play a key role in regulating exposures to sex steroid activity.
We hypothesised that there would be an association between umbilical cord concentration of SHBG, as a marker of fetal insulin resistance, concentrations of estrogens and T, and age at menarche. In addition to measuring estrogen and androgen concentrations using high sensitivity mass spectrometry/spectroscopy, we explored a measure of net estrogenic and androgenic activity which takes into consideration the varying concentrations, protein binding, bioavailability, and potency of the main estrogens and androgens in fetal circulation (18) .
METHODS

Participants
The Western Australian Pregnancy Cohort (Raine) Study (www.rainestudy.org.au) consists of 2,868 unselected pregnancies. Participants were recruited and sampled from the a public tertiary referral antenatal clinic (King Edward Memorial Hospital in Perth, Western Australia) between 1989-91 to study the effects of repeated ultrasound on fetal and postnatal growth and development, and on pregnancy outcomes. The study was approved by the King Edward Memorial Hospital/University of Western Australia ethics committees. As pre-viously described (19) , 50% of women attending the clinic were eligible for recruitment, of whom 90% agreed to participate in the study. Pregnant women completed a questionnaire at 18 and 34 weeks' gestation, which provided information on a wide range of variables including ethnicity, social and economic circumstances, lifestyle, medical history, and environmental exposures. Pregnancy and neonatal outcome data were abstracted from hospital notes. Of the 2,868 participants in the cohort, 1,415 were randomised to the intensive ultrasound arm of the study, which included umbilical cord blood sampling, and formed the study population for the present analysis. There were no differences in demographics between the pregnancies in the control arm and ultrasound intensive arm (19) . Immediately after delivery, mixed umbilical arterial-venous (UA:UV) cord blood was collected, allowed to clot and serum was frozen at À80 C and stored without thawing until analysed for this study. Cord blood samples were collected and sex steroids measured in 429 female infants.
Age at Menarche
Age at menarche was determined in 1000 cohort participants. Parents were sent a questionnaire at aged 10 years to be returned to the study coordinator indicating the date of the first and next three menstrual periods. If the questionnaire was not returned, the girls and their parents (usually mothers) were asked again at aged 14, 18 and 20 years. For greater precision, the calendar date (rather than age) at menarche was collected (day/month/year). Missing information was obtained by telephone contact before aged 22 years. A total of 286 women had both umbilical cord sex steroid measurements and menarche data collected and comprised the sample of the present study.
Estrogen and Androgen Analysis
All endocrine assays were performed blinded to sample identity. Estrogens (20) and androgens (21) were measured after extraction by liquid chromatography-tandem mass spectrometry (LC-MS/MS) as previously described. The calibration curves ranged from 0.5 to 50 ng/mL for E1, E2 and E4, and 5 to 500 ng/mL for E3. The limits of quantitation of the E1, E2, E3 and E4 assays were 1.8, 1.8, 17.8 and 1.8 nmol/L, respectively. Within-study (n ¼ 42) and prestudy (n ¼ 12) precision was <8.6%. All four estrogens were present in detectable concentrations in almost all samples. There were two samples with E1 levels below the limit of quantitation, one with undetectable E2 concentrations, two with undetectable E3 levels, and two with E4 levels below the limit of detection; all of these samples had very low levels of all four estrogens.
The limits of quantitation for TT, A4 and DHEA were 0.025, 0.05 and 0.05 ng/ml, respectively (0.08, 0.17 and 0.17 nmol/L). Inter-assay imprecision was 5-8%, 5-14% and 8-11% for TT, A4 and DHEA, respectively (n ¼ 24). Recovery of target analytes from stripped serum across three concentrations ranged from 93-98% (TT), 104-111% (A4) and 93-96% (DHEA). SHBG was measured by ELISA using a commercial kit (IBL International, Hamburg, Germany) according to the manufacturer's instructions as previously described (21) . The inter-assay imprecision (CV) was <4.5% (n ¼ 25); intra-assay CV was 5.2% (n ¼ 861).
Calculation of Bioavailable Androgen and Estrogen Concentrations
We employed an empirical method for calculating free T, validated for use in samples with low TT and SHBG concentrations (22) . Bioavailable T (BioT), representing the fraction of total T either free (unsequestered by SHBG) or bound to serum albumin, was calculated by summing the concentrations of free T and albumin-bound T (21, 23) . To calculate bioavailable E1 (BioE1) and E2 (BioE2) we used the method of Mazer (24) as previously published (23) . We calculated composite measures of total androgen (A B ) and estrogen (E B ) bioactivity, taking into account the biological potency, binding affinity, and unbound fraction of each hormone, as previously described (23) . The ratio of T to E2 levels was calculated by dividing the BioT concentration by the BioE2 concentration (BioT:BioE2). Similarly, the androgen to estrogen composite ratio was calculated by dividing A B by E B (A B :E B ).
Metabolic Measures
Fasting blood samples were collected from 1377 cohort participants at 14 years of age. From these samples fasting glucose and serum insulin levels were measured. Of this sample, 194 participants also had both umbilical cord sex steroid measurements and menarche data collected.
Covariates
The concentrations of umbilical cord blood sex hormones may be affected by a number of obstetric and maternal factors. We have previously reported that the presence and duration of labour and gestational age at delivery significantly affect androgen and estrogen concentrations in cord blood (20, 21) . In addition, birth weight and the presence of antepartum haemorrhage or preeclampsia significantly affect cord estrogen concentrations (20) . All these covariates were taken into account in the multivariable analyses.
A number of socio-demographic variables thought to affect age of menarche were also investigated. Socioeconomic factors, such as family income and parental education, maternal smoking during pregnancy, and greater body mass index (BMI) in childhood (1, 25, 26) , have all been associated with age at menarche. Heavier birthweight has also been associated with a reduced chance of early menarche (25) . The relationship between these variables and age of menarche was examined and the significant sociodemographic covariates were included in the multivariable analyses.
Statistical Analysis
Data were analysed using IBM SPSS for Windows version 22.0 and all hypothesis tests were two-sided, with P-values less than 0.05 considered statistically significant. Bivariate correlations were initially used to examine the relationship between age at menarche and the socio-demographic covariates. Those with a statistically significant correlation were included in the multivariable analyses. The relationships between age at menarche and sex steroid concentrations and ratios were investigated using hierarchical multiple linear regression analyses. In all regression models, the covariates were entered in the first step to control for any associated variance in age at menarche. The hormone measures of interest were then entered in a second step to examine the unique contribution to predicting age at menarche.
Extreme outliers for the hormone measures and age at menarche were excluded from the multivariable analyses as they were likely to disproportionately impact the sample mean. Outliers were defined as values that were further than 3 times the interquartile range from either the 75 th percentile (upper quartile) or 25 th percentile (lower quartile).
RESULTS
Maternal education and BMI at 8 years were found to be significantly associated with age at menarche. Lower maternal education (r ¼ À.16, P ¼ .006) and higher body mass index (BMI) at aged 8 years (r ¼ À.16, P ¼ .010) were associated with earlier age at menarche. These variables were subsequently included in the multivariable analyses. Table 1 presents the means and standard deviations for the hormone measures, metabolic measures, age at menarche, and covariates of the included and excluded female participants of the Raine study in current study sample, as well as between sample comparisons. Table 2 presents pairwise correlations between study variables, and Tables 3 and 4 present the results of the multivariable analyses conducted predicting age at menarche.
Sex Steroids
The first regression model investigated the relationship between umbilical cord sex steroid concentrations and age at menarche ( Table 3 ). Analyses to test for the assumption of collinearity found that multicollinearity was not an issue (Tolerance ¼ 0.21 to 0.97; VIF ¼ 1.03 to 4.81). The covariates accounted for a significant proportion of the variance in age at menarche, with higher maternal education, higher BMI, and the presence of APH all associated with earlier age at menarche. The inclusion of the sex steroid concentrations also accounted for a significant proportion of the variance in age at menarche (R 2 ¼ .069, P ¼ .029). Further, there was a significant association between umbilical cord concentrations of E4 and age at menarche (b ¼ À.208, P ¼ .020), indicating that higher umbilical cord concentrations of E4 were associated with earlier age at menarche. Table 4 presents the results from the second regression model examining the relationship between bioavailable umbilical cord sex steroid concentrations and age at menarche.
The assumption of collinearity was met for this analysis (Tolerance ¼ 0.21 to 0.97; VIF ¼ 1.03 to 4.86). Similar to the first model, the maternal education, BMI, and APH were all associated with age at menarche. The bioavailable sex steroid measures accounted for a higher proportion of variance than the absolute steroid concentrations (R 2 ¼ .083, P ¼ .008). In this model, both E4 (b ¼ À.216, P ¼ .016) and SHBG (b ¼ .156, P ¼ .037) were significantly associated with age at menarche. Higher E4 and lower SHBG umbilical cord concentrations were associated with earlier age at menarche.
Additional regression models were used to investigate the possible contribution of the composite variables and sex steroid ratios to age at menarche. The addition of the composite variables to the model did not account for a significant proportion of variance in age at menarche (R 2 ¼ . 
Metabolic Measures
Partial correlations were conducted to examine the association between metabolic measures at 14 years of age and age at menarche, while controlling for the influence of maternal .527** .514** .781** .958** .830** À.346** À.395** .078 À.031 À.146* À.101 .027 À.008 À.067 .051 .087 À.172** À.095 À.105 9. E3
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.801** À.310** À.364** À.158** À.039 À.141* À. education and BMI. Fasting glucose (r ¼ .266, P< .001), but not fasting insulin (r ¼ À.043, P ¼ .569), was significantly associated with age at menarche, such that lower fasting glucose was related to earlier age at menarche.
DISCUSSION
Using high sensitivity mass spectrometry/spectroscopy in a large community based pregnancy cohort we demonstrated an association between late gestation SHBG, sex steroid concentrations and age at menarche. Lower umbilical cord SHBG and higher E4 concentrations significantly predicted early age at menarche. Other umbilical cord concentrations of sex steroids were not significantly related to age at menarche. Our findings are consistent with a longitudinal study of SHBG levels in childhood which reported that lower circulating SHBG concentrations are associated with earlier age at menarche (27) but extend these findings to include the prenatal period. SHBG is produced by the liver and the placenta and functions to transport sex steroids in the circulation and regulate sex steroid bioavailability through binding. Because of the higher affinity of SHBG for dihydrotestosterone and T, compared to E2, SHBG also has profound effects on the balance between bioavailable androgens and estrogens. In children, hyperinsulinemia and low concentrations of SHBG are associated with greater body size in childhood and earlier age at menarche (28, 29) . The mechanisms driving lower umbilical cord SHBG concentrations are poorly understood, but are not directly related to maternal pre-pregnancy weight, weight gain during pregnancy, or neonatal adiposity (30) . Hyperinsulinemia could potentially be driving the association between lower prenatal SHBG and age at menarche through activation of the HPA axis and earlier onset of puberty (31) . This is consistent with previous findings that lower birth weight with rapid catch-up growth in childhood leads to earlier age at menarche (32) and increased metabolic dysfunction in early adulthood (33) . Hyperinsulinaemia in early life may suppress hepatic SHBG production (34) . Unfortunately, insulin was not measured in these umbilical cord samples so it was not possible to examine the association with age at menarche.
It is unclear why fasting glucose, but not fasting insulin in adolescence was associated with age at menarche. This may be a chance finding due to the partial correlation performed, or may reflect the known hyperinsulinaemia of adolescence and its temporal relation to adrenarche (adrenal puberty) not the milestone used in our study, menarche, which is modulated by ovarian activity (35) . A further interesting finding was the association of E4 with the age of menarche. As E4 is synthesised by the fetal liver from E2 and E3 precursors, and is not bound to SHBG (12) , this again may relate to the fetal metabolism altering fetal hepatic activity. The difference in age at menarche between girls in the lowest quartile of umbilical cord SHBG concentrations and those in the highest quartile was relatively small at only 3 months (age 12.63 years compared to 12.94 years). Because we measured date of menarche (rather than age at menarche in whole years as is commonly recorded), we were able to detect these relatively small differences. It is well established that lower circulating concentrations of SHBG are associated with an increased risk of developing Type II diabetes in later life (14) . Our findings suggest that earlier menarche may be a marker for subsequent cardiometabolic risk (4, 36) , and ongoing follow-up of this cohort through adulthood will address this hypothesis.
Limited studies from selected populations have suggested that prenatal sex steroid exposures may impact on pubertal timing and progression. Small studies from girls with classical congenital adrenal hyperplasia suggests that higher prenatal androgen exposures are associated with earlier adrenarche, but not necessarily earlier age at menarche (37). Prospective follow-up of daughters of women with PCOS indicate a subgroup with elevated T (38) , and increased basal and poststimulated DHEAS concentrations (38) , but have not reported differences in age at menarche compared to the general population. Supraphysiological prenatal estrogen exposure (as diethystilbestrol) is associated with earlier age at menarche (39) , but there are limited data from the general population and findings are conflicting (40, 41) . We have previously reported in a smaller subset of the Raine cohort that umbilical cord concentrations of T alone did not predict age at menarche (42) .
Direct measurement of prenatal sex steroid exposures in normal pregnancy is challenging. Currently umbilical cord measurements are the only practical way of directly measuring late gestation fetal sex steroid concentrations in unselected pregnancies (20, 21) . Maternal circulating sex steroid concentrations do not correlate with fetal levels, and whilst amniotic fluid concentrations may reflect sex steroids at mid-gestation (43) , amniocentesis is restricted to high-risk pregnancies because of attendant risks. Umbilical cord sex steroid concentrations reflect circulating fetal values in late gestation with minimal maternal contamination (20, 21) . Arterial and venous sex steroid concentrations are closely correlated, so separation of vessel source is not required for accurate measurement from the fetal circulation (44) . We and others have shown that umbilical cord blood sex steroids are most accurately measured using mass spectrometry, since an abundance of interfering substances and cross-reacting steroids and their conjugates in cord blood interfere with conventional radioimmunoassay (21) . While research has typically focussed on the most bioactive sex steroids, E2 and T, accurate assessment of prenatal sex steroid concentrations should include measurement of all biologically active estrogens and androgens and take into account their varying potency and binding protein affinity. E2 and T circulate tightly bound to SHBG and only the small free (unbound) fraction is thought to be biologically active (45) . Other sex steroids are not bound by SHBG, and circulate in the free form or loosely bound to albumin. Hence, their bioavailability is relatively high, although their ability to ligate the estrogen or androgen receptors is relatively weak (23) .
The strengths of our data include prospective design, large sample size (>10 times those of previous studies), detailed prospective collection of prenatal and reproductive characteristics and high specificity LC-MS/MS assay. In addition, our models accounted for various factors known to affect sex steroid and SHBG concentrations in umbilical cord blood, such as delivery mode, which have not been accounted for in previous studies examining age at menarche. Our sample were ethnically homogenous (96% Caucasian) which means that we cannot comment on ethnic differences that may contribute to both prenatal sex steroid exposures and to age at menarche.
In summary, we have shown that lower umbilical cord SHBG is associated with earlier age at menarche in a large population-based sample. These observations provide new information about prenatal factors influencing female reproductive function and potentially influencing later life health.
